ArticleMedical oncology (Northwood, London, England)2025
Natural Nrf2 activators modulate antioxidant gene expression and apoptosis in leukemic K-562 cells.
Article in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Natural products (NPs) have long been used in traditional medicine and continue to be explored for their chemopreventive and therapeutic properties. Many of their biological effects are mediated through redox-sensitive pathways, such as the nuclear factor erythroid 2-related factor 2 (Nrf2), a key regulator of antioxidant responses and cellular defense mechanisms. This study aimed to evaluate the antioxidant capacity, cytotoxicity, pro-apoptotic activity, and Nrf2-modulating effects of 22 natural product extracts traditionally used in ethnomedicine in a human leukemic K-562 cell model. The extracts were assessed for total phenolic content (TPC), radical scavenging activity (DDPH and ABTS assays), cytotoxic effects (AlamarBlue assay), apoptosis induction (caspase-3 activity), and regulation of Nrf2 target genes (HO-1, NQO1 and GCLC) via RT‒qPCR. The extracts exhibited a wide range of antioxidant and cytotoxic activities. Punica granatum, Rhodiola rosea, and Thymus vulgaris showed high phenolic content and antioxidant potential. R. rosea displayed the most potent cytotoxic effect, whereas Hypericum perforatum induced the highest caspase-3 activity. Gene expression revealed that T.vulgaris, R.rosea, Moringa oleifera, Withania somnifera, Saliva officinalis and Euphrasia officinalis upregulated all three Nrf2 target genes, with T.vulgaris showing the greatest induction. These findings highlight the pharmacological potential of traditionally used natural products as modulators of redox signaling and apoptosis inducers in leukemia cells. The activation of the Nrf2 pathway by the selected extracts supports further investigation of their potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.